Published on
July 1, 2025
- 10:05 GMT
Lutroo Imaging Begins Phase 1 Clinical Trial of Radiocaine™, a First-in-Class PET Radiotracer for Pain Imaging
Study marks first-in-human use of Radiocaine™ to image pain-related sodium channels with positron emission tomography (PET) PALO ALTO, CA, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- Lutroo Imaging, a clinical-stage molecular imaging company, …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Science
...
